Kuwait Report

Fouad M.T. Alghanim, Chairman and CEO of Fouad Alghanim and Sons Group talks about the investment strategy of one of the largest conglomerates in Kuwait.

He says, "We are looking at an important medical discovery in the US. Certain renowned professors have worked on producing new medicines to treat Alzheimer’s and Parkinson’s. I was approached by a famous doctor friend of mine in the US when he discovered this possibility. It needs finance to develop it. I immediately grasped the opportunity and gave it the go-ahead. I financed the project. I think it will go to the FDA in early January. I am confident that it will get a favorable response from the FDA. It’s a much needed medicine today. This is a major product that could be a big breakthrough."